BeyondSpring (BYSI) Cash from Financing Activities (2016 - 2026)

BeyondSpring (BYSI) posted Cash from Financing Activities of -$4.2 million for Q1 2026, down 310.91% sequentially from $2.0 million in Q4 2025.

BeyondSpring (BYSI) Cash from Financing Activities (2016 - 2026) Analysis & Trends

BeyondSpring has reported Cash from Financing Activities for 9 years, with the latest figure at -$4.2 million in Q1 2026.

Quarterly Cash from Financing Activities changed N/A year-over-year to -$4.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $811000.0 (down 96.59% YoY) and the FY2025 annual result came in at $5.0 million, down 81.45% from the prior year.
Cash from Financing Activities fell to -$4.2 million in Q1 2026 per BYSI's latest filing, from $2.0 million in the prior quarter.
Over five years, Cash from Financing Activities peaked at $21.9 million in Q3 2024 and troughed at -$4.2 million in Q1 2026.
A 3-year average of $4.9 million and a median of $2.0 million in 2025 frame the typical range for Cash from Financing Activities.
The widest YoY moves for Cash from Financing Activities: up 6.95% in 2025, down 86.34% in 2025.
Over 3 years, Cash from Financing Activities stood at $1.8 million in 2024, then grew by 6.95% to $2.0 million in 2025, then plunged by 310.91% to -$4.2 million in 2026.
According to Business Quant data, Cash from Financing Activities over the past three periods registered -$4.2 million, $2.0 million, and $3.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Cash from Financing Activities (Qtr)
1	Vertex Pharmaceuticals	139.13 Bn	131.28 Bn	2.84 Bn	-426.70 Mn
2	Regeneron Pharmaceuticals	85.77 Bn	77.77 Bn	3.93 Bn	-1.22 Bn
3	Argenx Se	64.64 Bn	59.46 Bn	1.37 Bn	-
4	Moderna	58.29 Bn	53.16 Bn	52.00 Mn	14.00 Mn
5	BeOne Medicines	41.92 Bn	36.82 Bn	1.53 Bn	-6.05 Mn
6	Alnylam Pharmaceuticals	31.58 Bn	28.28 Bn	992.69 Mn	36.24 Mn
7	BioNTech SE	28.12 Bn	9.73 Bn	668.28 Mn	-16.65 Mn
8	Insmed	27.39 Bn	26.22 Bn	358.27 Mn	27.18 Mn
9	Royalty Pharma	27.27 Bn	26.43 Bn	-	-273.15 Mn
10	BeyondSpring	29.85 Mn	29.85 Mn	-	-74,000.00

Download Data